KYTX · Kyverna Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Kyverna Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company. The Company Is Focused On Developing Cell Therapies For Patients Suffering From Autoimmune Diseases. Its Product, Kyv-101, Is An Autologous Cd19 Car T-Cell Product Candidate Made From An Underlying Chimeric Antigen Receptor, Or Car. It Is Also Developing Kyv-201, An Allogeneic Therapy Containing The Same Car As Kyv-101, To Develop It In Multiple Autoimmune Diseases.

HealthcareNasdaqUSMid Float

FLOAT

36.8M

FREE FLOAT %

59%

SHARES O/S

61.8M

MARKET CAP

$333.3M

EXCHANGE

Nasdaq

COUNTRY

KYTX Catalyst History

No catalysts recorded for KYTX yet

Day Trader Sniper hasn't classified a publishable catalyst for KYTX yet. New events appear here as they're scored.

Be early on the next KYTX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

KYTX · Kyverna Therapeutics, Inc.

KYTX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.